163 related articles for article (PubMed ID: 29319460)
1. Polymorphism of Opioid Receptors μ1 in Highly Hypnotizable Subjects.
Presciuttini S; Curcio M; Sciarrino R; Scatena F; Jensen MP; Santarcangelo EL
Int J Clin Exp Hypn; 2018; 66(1):106-118. PubMed ID: 29319460
[TBL] [Abstract][Full Text] [Related]
2. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
3. Alcohol Consumption in Healthy OPRM1 G Allele Carriers and Its Association with Impulsive Behavior.
Pfeifer P; Sariyar M; Eggermann T; Zerres K; Vernaleken I; Tüscher O; Fehr C
Alcohol Alcohol; 2015 Jul; 50(4):379-84. PubMed ID: 25836994
[TBL] [Abstract][Full Text] [Related]
4. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
Schwantes-An TH; Zhang J; Chen LS; Hartz SM; Culverhouse RC; Chen X; Coon H; Frank J; Kamens HM; Konte B; Kovanen L; Latvala A; Legrand LN; Maher BS; Melroy WE; Nelson EC; Reid MW; Robinson JD; Shen PH; Yang BZ; Andrews JA; Aveyard P; Beltcheva O; Brown SA; Cannon DS; Cichon S; Corley RP; Dahmen N; Degenhardt L; Foroud T; Gaebel W; Giegling I; Glatt SJ; Grucza RA; Hardin J; Hartmann AM; Heath AC; Herms S; Hodgkinson CA; Hoffmann P; Hops H; Huizinga D; Ising M; Johnson EO; Johnstone E; Kaneva RP; Kendler KS; Kiefer F; Kranzler HR; Krauter KS; Levran O; Lucae S; Lynskey MT; Maier W; Mann K; Martin NG; Mattheisen M; Montgomery GW; Müller-Myhsok B; Murphy MF; Neale MC; Nikolov MA; Nishita D; Nöthen MM; Nurnberger J; Partonen T; Pergadia ML; Reynolds M; Ridinger M; Rose RJ; Rouvinen-Lagerström N; Scherbaum N; Schmäl C; Soyka M; Stallings MC; Steffens M; Treutlein J; Tsuang M; Wall TL; Wodarz N; Yuferov V; Zill P; Bergen AW; Chen J; Cinciripini PM; Edenberg HJ; Ehringer MA; Ferrell RE; Gelernter J; Goldman D; Hewitt JK; Hopfer CJ; Iacono WG; Kaprio J; Kreek MJ; Kremensky IM; Madden PA; McGue M; Munafò MR; Philibert RA; Rietschel M; Roy A; Rujescu D; Saarikoski ST; Swan GE; Todorov AA; Vanyukov MM; Weiss RB; Bierut LJ; Saccone NL
Behav Genet; 2016 Mar; 46(2):151-69. PubMed ID: 26392368
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
6. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis.
Arias A; Feinn R; Kranzler HR
Drug Alcohol Depend; 2006 Jul; 83(3):262-8. PubMed ID: 16387451
[TBL] [Abstract][Full Text] [Related]
7. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
Kapur S; Sharad S; Singh RA; Gupta AK
J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
[TBL] [Abstract][Full Text] [Related]
8. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
Yu Z; Wen L; Shen X; Zhang H
Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
[TBL] [Abstract][Full Text] [Related]
9. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
[TBL] [Abstract][Full Text] [Related]
10. Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia.
Solak Ö; Erdoğan MÖ; Yıldız H; Ulaşlı AM; Yaman F; Terzi ES; Ulu S; Dündar Ü; Solak M
Rheumatol Int; 2014 Sep; 34(9):1257-61. PubMed ID: 24671502
[TBL] [Abstract][Full Text] [Related]
11. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
12. The A118G single-nucleotide polymorphism of human μ-opioid receptor gene and use of labor analgesia.
Pettersson FD; Grönbladh A; Nyberg F; Sundström-Poromaa I; Åkerud H
Reprod Sci; 2012 Sep; 19(9):962-7. PubMed ID: 22527985
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
14. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
[TBL] [Abstract][Full Text] [Related]
16. μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.
Cieślińska A; Sienkiewicz-Szłapka E; Kostyra E; Fiedorowicz E; Snarska J; Wroński K; Tenderenda M; Jarmołowska B; Matysiewicz M
Tumour Biol; 2015 Jun; 36(6):4655-60. PubMed ID: 25618602
[TBL] [Abstract][Full Text] [Related]
17. The association between the OPRM1 A118G polymorphism and addiction in a Turkish population.
Türkan H; Karahalil B; Kadıoğlu E; Eren K; Gürol DT; Karakaya AE
Arh Hig Rada Toksikol; 2019 Jun; 70(2):97-103. PubMed ID: 31246565
[TBL] [Abstract][Full Text] [Related]
18. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
[TBL] [Abstract][Full Text] [Related]
19. Association of the
Sebold M; Garbusow M; Cerci D; Chen K; Sommer C; Huys QJ; Nebe S; Rapp M; Veer IM; Zimmermann US; Smolka MN; Walter H; Heinz A; Friedel E
J Psychopharmacol; 2021 May; 35(5):566-578. PubMed ID: 33726538
[TBL] [Abstract][Full Text] [Related]
20. Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects.
Bach P; Vollsta Dt-Klein S; Kirsch M; Hoffmann S; Jorde A; Frank J; Charlet K; Beck A; Heinz A; Walter H; Sommer WH; Spanagel R; Rietschel M; Kiefer F
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1128-35. PubMed ID: 25937240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
